ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN Stock Price, News & Analysis
Company Description
ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN (NYSE: USML) is a publicly traded company.
USML stock has gained 1.1% over the past year. Shares last traded at $43.38.
On a trailing twelve-month basis, ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN reported revenue of $47.7B with net income of $3.6B. The company operates at a net profit margin of 7.5%.
This page provides a comprehensive overview of USML stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN (USML) stock last traded at $43.38. Over the past 12 months, the stock has gained 1.1%.
USML Rankings
Latest News
SEC Filings
ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN has filed 10 recent SEC filings, including 10 Form 6-K. The most recent filing was submitted on June 3, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all USML SEC filings →
Financial Highlights
ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN generated $47.7B in revenue over the trailing twelve months, and net income was $3.6B, reflecting a 7.5% net profit margin. The company generated $24.6B in operating cash flow.
Upcoming Events
Short Interest History
Short interest in ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN (USML) currently stands at 28 shares, down 62.2% from the previous reporting period. Over the past 12 months, short interest has decreased by 62.7%.
Days to Cover History
Days to cover for ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN (USML) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 7.5 days.